<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000883.v1.p1" parentStudy="phs000883.v1.p1" createDate="2015-03-12" modDate="2015-03-12">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Stacey Gabriel, PhD</td><td>Broad Institute, Boston, MA, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Sekar Kathiresan, MD</td><td>Broad Institute and Massachusetts General Hospital, Boston, MA, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>MIGen_ExS: PROCARDIS</StudyNameEntrez>
	<StudyNameReportPage>Myocardial Infarction Genetics Exome Sequencing Consortium: Precocious Coronary Artery Disease Study</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Case-Control</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>The Precocious Coronary Artery Disease (PROCARDIS) study is an international, multicenter case-control study aimed at discovering the genetic contributors to premature coronary artery disease. All exome sequencing was performed at the Broad Institute of Harvard and MIT; samples sequence capture was performed using Agilent SureSelect Human All Exon Kit v2 and sequencing was performed on an Illumina HiSeq 2000 or 2500.</p>]]>
	</Description>
	<StudyInEx><![CDATA[
<p>Cases and controls were recruited from the United Kingdom. Cases were considered eligible for the study if premature coronary artery disease was present. This was defined as myocardial infarction (MI), unstable or stable angina, or coronary revascularization that occurred before age 66. 80% of cases had a sibling with a history of MI or acute coronary syndrome before age 66. Controls were matched by age and gender and recruited from the same centers simultaneously. Controls were eligible for the study if they had no personal or sibling history of MI, unstable or stable angina, or coronary revascularization before the age of 66.</p>]]>
	</StudyInEx>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="20032323"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Coronary Artery Disease"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Stacey Gabriel, PhD</AttName>
			<Institution>Broad Institute, Boston, MA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Sekar Kathiresan, MD</AttName>
			<Institution>Broad Institute and Massachusetts General Hospital, Boston, MA, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="DS-HTD" longName="Disease-Specific (Heart Disease)"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NHLBI</DacName>
      <DacFullName>National Heart, Lung, and Blood Institute DAC</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000883.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>0</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000883.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000883.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Disease-Specific (Heart Disease)</ConsentName>
        <ConsentAbbrev>DS-HTD</ConsentAbbrev>
        <UseLimitation>Use of the data must be related to Heart Disease.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
